We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+6.32%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$16.2B
AUM Growth
+$1.75B
Cap. Flow
+$1.1B
Cap. Flow %
6.8%
Top 10 Hldgs %
54.17%
Holding
115
New
28
Increased
36
Reduced
22
Closed
20

Top Buys

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$784M
2
ESRX
Express Scripts Holding Company
ESRX
+$504M
3
GD icon
General Dynamics
GD
+$348M
4
XL
XL Group Ltd.
XL
+$329M
5
KDP icon
Keurig Dr Pepper
KDP
+$194M

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$618M
2
MON
Monsanto Co
MON
+$543M
3
COL
Rockwell Collins
COL
+$151M
4
ABLX
Ablynx NV
ABLX
+$134M
5
PPLI
People Inc
PPLI
+$112M

Sector Composition

Rank Sector Weight
1 Healthcare 19.63%
2 Technology 19.02%
3 Financials 14.39%
4 Communication Services 11.46%
5 Industrials 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TFCF
26
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$174M 1.08%
3,537,500
-1,462,500
-29% -$57.2M
CTXS
27
DELISTED
Citrix Systems Inc
CTXS
$167M 1.03%
1,594,570
-719,684
-31% -$74.1M
LBTYK icon
28
Liberty Global Class C
LBTYK
$3.53B
$147M 0.91%
5,522,656
+624,563
+13% +$18.2M
LBTYA icon
29
Liberty Global Class A
LBTYA
$3.62B
$147M 0.91%
5,327,493
+613,567
+13% +$18.5M
AZN icon
30
AstraZeneca
AZN
$263B
$135M 0.83%
1,925,000
+142,500
+8% +$10.3M
ENTA icon
31
Enanta Pharmaceuticals
ENTA
$366M
$125M 0.77%
1,075,000
+160,000
+17% +$16M
RDUS
32
DELISTED
Radius Health, Inc.
RDUS
$120M 0.74%
4,086,300
– –
CI icon
33
Cigna
CI
$73.7B
$114M 0.7%
671,000
+491,000
+273% +$85M
KYNB
34
Kyntra Bio
KYNB
$27.2M
$108M 0.66%
68,700
– –
EFX icon
35
Equifax
EFX
$20.3B
$105M 0.65%
838,959
-565,869
-40% -$67.1M
GGP
36
DELISTED
GGP Inc.
GGP
$104M 0.64%
+5,085,000
New +$103M
SAGE
37
DELISTED
Sage Therapeutics
SAGE
$97.8M 0.6%
625,000
+180,000
+40% +$28.3M
ASND icon
38
Ascendis Pharma A/S
ASND
$16B
$96.9M 0.6%
1,457,297
+170,497
+13% +$11.2M
ANDV
39
DELISTED
Andeavor
ANDV
$80M 0.49%
+610,000
New +$80.3M
ARRY
40
DELISTED
Array Biopharma Inc
ARRY
$78M 0.48%
4,650,000
+1,555,000
+50% +$24.7M
ZGNX
41
DELISTED
Zogenix, Inc.
ZGNX
$74.9M 0.46%
1,695,500
+119,500
+8% +$4.93M
MYOK
42
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$73.5M 0.45%
1,481,278
+442,000
+43% +$21.4M
BIIB icon
43
Biogen
BIIB
$30B
$72.3M 0.45%
249,000
-91,000
-27% -$25.6M
XLRN
44
DELISTED
Acceleron Pharma
XLRN
$68M 0.42%
1,401,000
– –
TFCFA
45
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$61.4M 0.38%
+1,235,000
New +$48.8M
AVA icon
46
Avista
AVA
$3.34B
$58.5M 0.36%
1,111,723
+711,723
+178% +$37.2M
FOLD
47
DELISTED
Amicus Therapeutics
FOLD
$57.1M 0.35%
3,655,000
+174,000
+5% +$2.63M
IOVA icon
48
Iovance Biotherapeutics
IOVA
$1.82B
$56.6M 0.35%
4,425,000
+275,000
+7% +$4.02M
SINA
49
DELISTED
Sina Corp
SINA
$53.8M 0.33%
+635,000
New +$59.1M
GBT
50
DELISTED
Global Blood Therapeutics, Inc.
GBT
$53.6M 0.33%
+1,185,000
New +$54M
1
2
3 4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Farallon Capital Management held 115 positions worth $16.2B, up 12% from $14.4B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Farallon Capital Management deployed $1.1B of net new capital in Q2 2018, opening 28 new positions and adding to 36 existing holdings. Its largest new stake was General Dynamics: 1,697,715 shares worth $316M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was NXP Semiconductors, an estimated $618M trimmed.

  • Farallon Capital Management's largest Q2 2018 buy was General Dynamics: 1,697,715 shares worth $316M.
  • Farallon Capital Management added most to Altaba Inc in Q2 2018, an estimated $784M increase.
  • Farallon Capital Management's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $618M.
  • Farallon Capital Management fully exited Monsanto Co in Q2 2018, selling an estimated $543M.
  • Farallon Capital Management's ten largest holdings make up 54% of its $16.2B portfolio in Q2 2018.
  • Farallon Capital Management opened 28 new positions and closed 20 in Q2 2018.
  • Farallon Capital Management's portfolio value rose 12% quarter-over-quarter to $16.2B.

Based on Farallon Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.